prednisolone has been researched along with Chronic Hepatitis B in 49 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients (n = 213) with chronic hepatitis B were randomised to prednisolone (two weeks of 0." | 9.08 | [Pretreatment with prednisolone enhances the effect of human lymphoblastoid interferon in chronic hepatitis B]. ( Bassendine, M; Benhamou, JP; Berthelot, P; Bindslev, N; Enriquez, J; Krogsgaard, K; Lindberg, J; Marcellin, P; Ouzan, D; Ring-Larsen, H; Sanchez-Tapias, JM; Tran, A; Trepo, C, 1998) |
| "Following an acute episode of undifferentiated collagenosis/autoimmune disease with joint pain, a 50-year-old female patient with known long-standing chronic hepatitis B was treated orally with corticosteroids (30 mg prednisolone in decreasing doses over a period of six months)." | 7.72 | [Severe exacerbation of chronic hepatitis B during therapy with corticosteroids and lamivudine therapy and successful short-term combination therapy with interferon-beta and interferon-gamma]. ( Chrissafidou, A; Malek, M; Musch, E, 2003) |
| "A 50-year-old woman patient began receiving lamivudine because of acute exacerbation of chronic hepatitis B." | 7.71 | Repeated jaundice due to YMDD mutant in a patient with prolonged lamivudine therapy for chronic hepatitis B under prednisolone treatment for Still's disease. ( Hasegawa, K; Hashimoto, E; Hayashi, N; Iizuka, A; Ishikawa, K; Joh, R; Kanai, N; Naritomi, T; Ogawa, M; Shizuma, T; Torii, N, 2002) |
| "A 21 year-old male patient with chronic hepatitis B was treated with lamivudine 150 mg daily after withdrawal of a short course of oral prednisolone (30 mg daily for 3 weeks, 15 mg daily for 1 week)." | 7.70 | Case report: dramatic response to lamivudine therapy following corticosteroid priming in chronic hepatitis B. ( Chien, RN; Liaw, YF, 1999) |
| "In Asian patients with chronic hepatitis B, quantitative analyses of subpopulations of peripheral blood lymphocytes have not been able to confirm these findings." | 6.69 | Quantitative monitoring of serum hepatitis B virus DNA and blood lymphocyte subsets during combined prednisolone and interferon-alpha therapy in patients with chronic hepatitis B. ( Fei, GZ; Hellström, UB; Sylvan, SP; Yao, GB, 1999) |
| "Patients (n = 213) with chronic hepatitis B were randomised to prednisolone (two weeks of 0." | 5.08 | [Pretreatment with prednisolone enhances the effect of human lymphoblastoid interferon in chronic hepatitis B]. ( Bassendine, M; Benhamou, JP; Berthelot, P; Bindslev, N; Enriquez, J; Krogsgaard, K; Lindberg, J; Marcellin, P; Ouzan, D; Ring-Larsen, H; Sanchez-Tapias, JM; Tran, A; Trepo, C, 1998) |
| "Following an acute episode of undifferentiated collagenosis/autoimmune disease with joint pain, a 50-year-old female patient with known long-standing chronic hepatitis B was treated orally with corticosteroids (30 mg prednisolone in decreasing doses over a period of six months)." | 3.72 | [Severe exacerbation of chronic hepatitis B during therapy with corticosteroids and lamivudine therapy and successful short-term combination therapy with interferon-beta and interferon-gamma]. ( Chrissafidou, A; Malek, M; Musch, E, 2003) |
| "A 50-year-old woman patient began receiving lamivudine because of acute exacerbation of chronic hepatitis B." | 3.71 | Repeated jaundice due to YMDD mutant in a patient with prolonged lamivudine therapy for chronic hepatitis B under prednisolone treatment for Still's disease. ( Hasegawa, K; Hashimoto, E; Hayashi, N; Iizuka, A; Ishikawa, K; Joh, R; Kanai, N; Naritomi, T; Ogawa, M; Shizuma, T; Torii, N, 2002) |
| "A 21 year-old male patient with chronic hepatitis B was treated with lamivudine 150 mg daily after withdrawal of a short course of oral prednisolone (30 mg daily for 3 weeks, 15 mg daily for 1 week)." | 3.70 | Case report: dramatic response to lamivudine therapy following corticosteroid priming in chronic hepatitis B. ( Chien, RN; Liaw, YF, 1999) |
| "Lamivudine (100 mg/day) was administrated 2 weeks before starting prednisolone and maintained 6 months after prednisolone withdrawal." | 2.79 | Comparison of prednisolone and lamivudine combined therapy with prednisolone monotherapy on carriers of hepatitis B virus with IgA nephropathy: a prospective cohort study. ( Fang, J; Li, D; Li, W; Tan, Z, 2014) |
| "Treatment with Prednisolone priming and Interferon, improved both the time and rate of seroconversion compared to no treatment or Interferon alone, suggesting that this combination of drugs might have an immunomodulatory effect." | 2.72 | Long-term follow-up of hepatitis B carrier children treated with interferon and prednisolone. ( Ballard, AL; Boxall, EH; Davies, P; Kelly, DA; Sira, J, 2006) |
| "In Asian patients with chronic hepatitis B, quantitative analyses of subpopulations of peripheral blood lymphocytes have not been able to confirm these findings." | 2.69 | Quantitative monitoring of serum hepatitis B virus DNA and blood lymphocyte subsets during combined prednisolone and interferon-alpha therapy in patients with chronic hepatitis B. ( Fei, GZ; Hellström, UB; Sylvan, SP; Yao, GB, 1999) |
| "Prednisolone pretreatment resulted in an increase in the proportion of mutant in patients with initially low percentages (< or = 25%) of mutant." | 2.69 | Olone modulates the therapeutic effect of interferon to eliminate preferentially the hepatitis B virus precore stop mutant. ( Chen, TC; Chu, CM; Hsieh, SY; Liaw, YF; Sheen, IS; Yeh, CT, 2000) |
| "Prednisolone was gradually withdrawn with the introduction of Entecavir 0." | 2.58 | Dermatomyositis as an extrahepatic manifestation of hepatitis B virus-related hepatocellular carcinoma: A case report and literature review. ( Han, J; Kwong, TNY; Liu, J; Wang, S, 2018) |
| " At the time points that prednisolone dosage was higher, higher levels of ALT, but no difference in AST levels was noted." | 1.72 | Prevalence and management of chronic hepatitis B in pemphigus and pemphigoid patients: New evidence for the safety of rituximab. ( Aryanian, Z; Balighi, K; Daneshpazhooh, M; Hatami, P; Mahmoudi, H; Mohseniafshar, Z; Soori, T; Tahooneban, A; Tavakolpour, S, 2022) |
| "A 28-year-old woman with a chronic hepatitis B virus infection developed nephrotic syndrome in her second month of pregnancy, with urinary protein levels of 3 to 10 g/d that continued into her postpartum period." | 1.51 | Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis: A case report. ( Akanuma, T; Akihisa, T; Amemiya, N; Honda, K; Horita, S; Inoue, T; Ito, Y; Kataoka, H; Kawachi, K; Kawasoe, K; Makabe, S; Manabe, S; Matsui, K; Mitobe, M; Mochizuki, T; Moriyama, T; Nitta, K; Ohara, M; Sato, M; Sawada, A; Suzuki, T, 2019) |
| "Acute-on-chronic hepatitis B liver failure (ACHBLF) refers to the acute deterioration of liver function during chronic hepatitis B virus infection, and is associated with high mortality, with rapid progression to death." | 1.51 | Glucocorticoid Regulates NLRP3 in Acute-On-Chronic Hepatitis B Liver Failure. ( Fan, YC; Fang, Y; Qian, Y; Wang, H; Wang, K; Wu, CS; Zhao, Q, 2019) |
| "Acute-onset CIDP resembles Guillain-Barre syndrome (GBS), a rapidly progressive disorder, and follows a chronic course." | 1.43 | Acute-onset chronic inflammatory demyelinating polyneuropathy in hantavirus and hepatitis B virus coinfection: A case report. ( Choi, EH; Lim, JY; Lim, YH, 2016) |
| "Mixed cryoglobulinemia is occasionally seen in patients with hepatitis B virus (HBV) infection." | 1.40 | Purpura with ulcerative skin lesions and mixed cryoglobulinemia in a quiescent hepatitis B virus carrier. ( Akimoto, T; Iwazu, K; Iwazu, Y; Komada, T; Kusano, E; Morishita, Y; Muto, S; Numata, A; Okuda, K; Saito, O; Sugase, T; Takemoto, F; Takeshima, E; Yamazaki, T; Yoshizawa, H, 2014) |
| "Patients with severe exacerbation of chronic hepatitis B, sometimes developing into fulminant liver failure, are at high risk for mortality even with antiviral therapy." | 1.35 | Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B. ( Arai, M; Fujiwara, K; Fukai, K; Imazeki, F; Oda, S; Sadahiro, T; Suzuki, A; Suzuki, H; Yasui, S; Yokosuka, O; Yonemitsu, Y, 2008) |
| "In the interferon (IFN) treatment of chronic hepatitis B, there is no accepted definition of virological response as measured by highly sensitive HBV DNA assays." | 1.31 | Virological response to interferon therapy of chronic hepatitis B as measured by a highly sensitive assay. ( Hannoun, C; Horal, P; Krogsgaard, K; Lindh, M, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (2.04) | 18.7374 |
| 1990's | 12 (24.49) | 18.2507 |
| 2000's | 20 (40.82) | 29.6817 |
| 2010's | 14 (28.57) | 24.3611 |
| 2020's | 2 (4.08) | 2.80 |
| Authors | Studies |
|---|---|
| Aryanian, Z | 1 |
| Tahooneban, A | 1 |
| Balighi, K | 1 |
| Daneshpazhooh, M | 1 |
| Mahmoudi, H | 1 |
| Soori, T | 1 |
| Mohseniafshar, Z | 1 |
| Tavakolpour, S | 1 |
| Hatami, P | 1 |
| Chou, CY | 1 |
| Lin, CW | 1 |
| Chen, GS | 1 |
| Huang, RY | 1 |
| Chou, JW | 1 |
| Lin, YL | 1 |
| Cheng, KS | 1 |
| Wu, PY | 1 |
| Reanne Ju, T | 1 |
| Han, J | 1 |
| Wang, S | 1 |
| Kwong, TNY | 1 |
| Liu, J | 1 |
| Kataoka, H | 1 |
| Mochizuki, T | 1 |
| Akihisa, T | 1 |
| Kawasoe, K | 1 |
| Kawachi, K | 1 |
| Makabe, S | 1 |
| Sawada, A | 1 |
| Manabe, S | 1 |
| Sato, M | 1 |
| Amemiya, N | 1 |
| Mitobe, M | 1 |
| Akanuma, T | 1 |
| Ito, Y | 1 |
| Inoue, T | 1 |
| Suzuki, T | 2 |
| Matsui, K | 1 |
| Moriyama, T | 1 |
| Horita, S | 1 |
| Ohara, M | 1 |
| Honda, K | 1 |
| Nitta, K | 1 |
| Zhao, Q | 1 |
| Wu, CS | 1 |
| Fang, Y | 1 |
| Qian, Y | 1 |
| Wang, H | 1 |
| Fan, YC | 1 |
| Wang, K | 1 |
| Fang, J | 1 |
| Li, W | 1 |
| Tan, Z | 1 |
| Li, D | 1 |
| Yamazaki, T | 1 |
| Akimoto, T | 2 |
| Okuda, K | 1 |
| Sugase, T | 1 |
| Takeshima, E | 1 |
| Numata, A | 1 |
| Morishita, Y | 1 |
| Iwazu, Y | 1 |
| Yoshizawa, H | 1 |
| Komada, T | 1 |
| Iwazu, K | 1 |
| Saito, O | 2 |
| Takemoto, F | 1 |
| Muto, S | 2 |
| Kusano, E | 2 |
| Song, JH | 1 |
| Kim, SY | 1 |
| Shin, JK | 1 |
| Hong, SD | 1 |
| Rim, KS | 1 |
| Park, HN | 1 |
| Lee, JH | 1 |
| Lee, YB | 1 |
| Oh, SH | 1 |
| Hwang, SG | 1 |
| Lim, JY | 1 |
| Lim, YH | 1 |
| Choi, EH | 1 |
| Fukuda, W | 1 |
| Hanyu, T | 1 |
| Katayama, M | 1 |
| Mizuki, S | 1 |
| Okada, A | 1 |
| Miyata, M | 1 |
| Handa, Y | 1 |
| Hayashi, M | 1 |
| Koyama, Y | 1 |
| Arii, K | 1 |
| Kitaori, T | 1 |
| Hagiyama, H | 1 |
| Urushidani, Y | 1 |
| Yamasaki, T | 1 |
| Ikeno, Y | 1 |
| Omoto, A | 1 |
| Sugitani, T | 1 |
| Morita, S | 1 |
| Inokuma, S | 1 |
| Fujiwara, K | 2 |
| Yasui, S | 1 |
| Yonemitsu, Y | 1 |
| Fukai, K | 1 |
| Arai, M | 1 |
| Imazeki, F | 2 |
| Suzuki, A | 1 |
| Suzuki, H | 2 |
| Sadahiro, T | 1 |
| Oda, S | 1 |
| Yokosuka, O | 3 |
| Yeo, W | 1 |
| Chan, TC | 1 |
| Leung, NW | 1 |
| Lam, WY | 1 |
| Mo, FK | 1 |
| Chu, MT | 1 |
| Chan, HL | 1 |
| Hui, EP | 1 |
| Lei, KI | 1 |
| Mok, TS | 1 |
| Chan, PK | 1 |
| Leung, VK | 1 |
| Lee, CK | 1 |
| Chau, TN | 1 |
| Cheung, WI | 1 |
| Lo, FH | 1 |
| Lai, KB | 1 |
| Lin, CK | 1 |
| Naniwa, T | 1 |
| Maeda, T | 1 |
| Shimizu, S | 1 |
| Ito, R | 1 |
| Otake, T | 1 |
| Tanaka, A | 1 |
| Takahashi, H | 1 |
| Higashizawa, T | 1 |
| Inoue, M | 1 |
| Nishino, K | 1 |
| Isoda, N | 1 |
| Sugano, K | 1 |
| Wong, MH | 1 |
| Sockalingam, S | 1 |
| Zain, A | 1 |
| Fylaktou, A | 1 |
| Daoudaki, M | 1 |
| Dimou, V | 1 |
| Sianou, E | 1 |
| Papaventsis, D | 1 |
| Mavrovouniotis, I | 1 |
| Fouzas, I | 1 |
| Papanikolaou, V | 1 |
| Kanazawa, N | 1 |
| Izumi, N | 1 |
| Kawamura, S | 1 |
| Tsuchiya, K | 1 |
| Hamano, K | 1 |
| Itakura, J | 1 |
| Asahina, Y | 1 |
| Noguchi, O | 1 |
| Uchihara, M | 1 |
| Miyake, S | 1 |
| Sakai, T | 1 |
| Joh, R | 1 |
| Hasegawa, K | 1 |
| Torii, N | 1 |
| Ogawa, M | 1 |
| Kanai, N | 1 |
| Naritomi, T | 1 |
| Ishikawa, K | 1 |
| Iizuka, A | 1 |
| Shizuma, T | 1 |
| Hashimoto, E | 1 |
| Hayashi, N | 1 |
| Milovanova, SIu | 1 |
| Abdurakhmanov, DT | 1 |
| Kozlovskaia, NL | 1 |
| Tégaĭ, SV | 1 |
| Aprosina, ZG | 1 |
| Arase, Y | 2 |
| Kumada, H | 3 |
| Yano, M | 1 |
| Takaki, A | 1 |
| Nakatsuka, A | 1 |
| Satou, C | 1 |
| Iwata, Y | 1 |
| Ikeda, H | 1 |
| Fukushima, M | 1 |
| Musch, E | 1 |
| Malek, M | 1 |
| Chrissafidou, A | 1 |
| Chroni, E | 1 |
| Thomopoulos, C | 1 |
| Papapetropoulos, S | 1 |
| Paschalis, C | 1 |
| Karatza, CL | 1 |
| Hinds, R | 1 |
| Dhawan, A | 1 |
| Kanda, T | 2 |
| Yoshida, S | 1 |
| Suzuki, Y | 2 |
| Nagao, K | 1 |
| Saisho, H | 2 |
| Akuta, N | 1 |
| Kojima, H | 1 |
| Hirasawa, H | 1 |
| Giacchino, R | 1 |
| Facco, F | 1 |
| Giambartolomei, G | 1 |
| Navone, C | 1 |
| Timitilli, A | 1 |
| Cristina, E | 1 |
| Cirillo, C | 1 |
| Barigione, G | 1 |
| Terragna, A | 1 |
| Maier, KP | 1 |
| Boxall, EH | 1 |
| Sira, J | 1 |
| Ballard, AL | 1 |
| Davies, P | 1 |
| Kelly, DA | 1 |
| Gotto, J | 1 |
| Webster, GJ | 1 |
| Brown, D | 1 |
| Jenkins, J | 1 |
| Dusheiko, GM | 1 |
| Bertoletti, A | 1 |
| Kuwahara, R | 1 |
| Saitsu, H | 1 |
| Abe, M | 1 |
| Takata, A | 1 |
| Tanaka, K | 1 |
| Hino, T | 1 |
| Ide, T | 1 |
| Kuromatsu, R | 1 |
| Tanikawa, K | 1 |
| Kage, M | 1 |
| Kumashiro, R | 1 |
| Sata, M | 1 |
| Thong, BY | 1 |
| Koh, ET | 1 |
| Chng, HH | 1 |
| Chow, WC | 2 |
| Ng, HS | 1 |
| Kim, HS | 1 |
| Kim, JW | 1 |
| Chung, KS | 1 |
| Krogsgaard, K | 2 |
| Marcellin, P | 1 |
| Trepo, C | 1 |
| Berthelot, P | 1 |
| Sanchez-Tapias, JM | 1 |
| Bassendine, M | 1 |
| Tran, A | 1 |
| Ouzan, D | 1 |
| Ring-Larsen, H | 1 |
| Lindberg, J | 1 |
| Enriquez, J | 1 |
| Benhamou, JP | 1 |
| Bindslev, N | 1 |
| Lin, SM | 1 |
| Sheen, IS | 2 |
| Chien, RN | 3 |
| Chu, CM | 3 |
| Liaw, YF | 4 |
| Im, EH | 1 |
| Lee, BS | 1 |
| Sung, JK | 1 |
| Lee, SO | 1 |
| Lee, KT | 1 |
| Lee, SM | 1 |
| Kim, SH | 1 |
| Seo, KS | 1 |
| Kim, JH | 1 |
| Kim, SG | 1 |
| Kim, NJ | 1 |
| Lee, HY | 1 |
| Ikeda, K | 1 |
| Murashima, N | 1 |
| Chayama, K | 1 |
| Tsubota, A | 1 |
| Koida, I | 1 |
| Saitoh, S | 1 |
| Kobayashi, M | 2 |
| Fei, GZ | 1 |
| Sylvan, SP | 1 |
| Yao, GB | 1 |
| Hellström, UB | 1 |
| Stamenkovic, SA | 1 |
| Alphonso, N | 1 |
| Rice, P | 1 |
| Madden, BP | 1 |
| Yeh, CT | 2 |
| Chen, TC | 1 |
| Hsieh, SY | 1 |
| Tsai, SL | 1 |
| Lindh, M | 1 |
| Hannoun, C | 1 |
| Horal, P | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Safety and Efficacy of Steroids in the Management of Fulminant Hepatic Failure Due to Hepatitis A Virus in the Pediatric Age Group[NCT02375867] | Phase 4 | 33 participants (Actual) | Interventional | 2015-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 reviews available for prednisolone and Chronic Hepatitis B
| Article | Year |
|---|---|
Dermatomyositis Induced by Hepatitis B Virus-related Hepatocellular Carcinoma: A Case Report and Review of the Literature.
Topics: Anti-Inflammatory Agents; Carcinoma, Hepatocellular; Dermatomyositis; Disease Progression; Hepatitis | 2017 |
Dermatomyositis as an extrahepatic manifestation of hepatitis B virus-related hepatocellular carcinoma: A case report and literature review.
Topics: alpha-Fetoproteins; Antiviral Agents; Carcinoma, Hepatocellular; Catheter Ablation; Dermatomyositis; | 2018 |
[Acute exacerbation by reactivation of HBV in steroid withdrawal therapy].
Topics: Adult; Female; Hepatitis B, Chronic; Humans; Male; Middle Aged; Prednisolone; Substance Withdrawal S | 1995 |
[Corticosteroid withdrawal therapy for hepatitis B].
Topics: Adult; Hepatitis B, Chronic; Humans; Male; Prednisolone; Substance Withdrawal Syndrome | 1995 |
Treatment of chronic hepatitis B--a paediatric perspective.
Topics: Antiviral Agents; Hepatitis B, Chronic; Humans; Interferons; Lamivudine; Pediatrics; Prednisolone | 2003 |
[Corticosteroid withdrawal therapy in patients with chronic hepatitis B virus infection].
Topics: Alanine Transaminase; Antiviral Agents; CD8 Antigens; DNA, Viral; Drug Administration Schedule; Drug | 2004 |
[Drug therapy in chronic liver disease].
Topics: Adenine; Administration, Oral; Anti-HIV Agents; Antiviral Agents; Azathioprine; Cholangitis, Scleros | 2005 |
8 trials available for prednisolone and Chronic Hepatitis B
| Article | Year |
|---|---|
Comparison of prednisolone and lamivudine combined therapy with prednisolone monotherapy on carriers of hepatitis B virus with IgA nephropathy: a prospective cohort study.
Topics: Adult; Alanine Transaminase; Anti-Inflammatory Agents; Antiviral Agents; Carrier State; Drug Therapy | 2014 |
Importance of adequate immunosuppressive therapy for the recovery of patients with "life-threatening" severe exacerbation of chronic hepatitis B.
Topics: Acute Disease; Adult; Aged; Female; Glucocorticoids; Hepatitis B, Chronic; Humans; Immunosuppressive | 2005 |
Long-term follow-up of hepatitis B carrier children treated with interferon and prednisolone.
Topics: Adolescent; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Carrier State; Chil | 2006 |
[Pretreatment with prednisolone enhances the effect of human lymphoblastoid interferon in chronic hepatitis B].
Topics: Adult; Aged; Anti-Inflammatory Agents; Contraindications; Drug Synergism; Europe; Female; Hepatitis | 1998 |
Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Carcinoma, Hepatocellular; Drug Therapy, Combination; F | 1999 |
T cell subsets in chronic hepatitis B and the effect of prednisolone withdrawal and interferon alpha-2b.
Topics: Adult; DNA, Viral; Female; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B, Chronic; Hum | 1999 |
Quantitative monitoring of serum hepatitis B virus DNA and blood lymphocyte subsets during combined prednisolone and interferon-alpha therapy in patients with chronic hepatitis B.
Topics: Adult; Antiviral Agents; CD4-CD8 Ratio; DNA, Viral; Drug Therapy, Combination; Female; Fluorescent A | 1999 |
Olone modulates the therapeutic effect of interferon to eliminate preferentially the hepatitis B virus precore stop mutant.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Antiviral Agents; Drug Interactions; Hepatiti | 2000 |
34 other studies available for prednisolone and Chronic Hepatitis B
| Article | Year |
|---|---|
Prevalence and management of chronic hepatitis B in pemphigus and pemphigoid patients: New evidence for the safety of rituximab.
Topics: Hepatitis B Surface Antigens; Hepatitis B, Chronic; Humans; Pemphigoid, Bullous; Pemphigus; Predniso | 2022 |
Mucous membrane pemphigoid in a patient with chronic hepatitis B virus infection: A case report.
Topics: Adult; Biopsy; Dose-Response Relationship, Drug; Hepatitis B, Chronic; Humans; Male; Mouth Mucosa; P | 2021 |
Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis: A case report.
Topics: Adult; Antiviral Agents; Female; Glomerulonephritis, Membranoproliferative; Guanine; Hepatitis B vir | 2019 |
Glucocorticoid Regulates NLRP3 in Acute-On-Chronic Hepatitis B Liver Failure.
Topics: Acute-On-Chronic Liver Failure; Adult; Female; Gene Expression Regulation; Glucocorticoids; Hepatiti | 2019 |
Purpura with ulcerative skin lesions and mixed cryoglobulinemia in a quiescent hepatitis B virus carrier.
Topics: Aged; Antiviral Agents; Combined Modality Therapy; Cryoglobulinemia; Cryoglobulins; DNA, Viral; Fema | 2014 |
[A Case of Severe Peripheral Polyneuropathy Occurring after Entecavir Treatment in a Hepatitis B Patient].
Topics: Administration, Oral; Antiviral Agents; Brain; Drug Therapy, Combination; Duloxetine Hydrochloride; | 2016 |
Acute-onset chronic inflammatory demyelinating polyneuropathy in hantavirus and hepatitis B virus coinfection: A case report.
Topics: Acute Disease; Adult; Azathioprine; Carrier State; Coinfection; Exercise Therapy; Follow-Up Studies; | 2016 |
Incidence of hepatitis B virus reactivation in patients with resolved infection on immunosuppressive therapy for rheumatic disease: a multicentre, prospective, observational study in Japan.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; DNA, Viral; Female; Hepatitis B Antibodies; Hepatitis B | 2017 |
Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis B.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis B, Chronic; H | 2008 |
Hepatitis B virus reactivation in lymphoma patients with prior resolved hepatitis B undergoing anticancer therapy with or without rituximab.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineo | 2009 |
A probable case of transfusion-transmitted hepatitis B virus infection in an immunosuppressed recipient caused by an occult HBV-infected donor with negative ID-NAT.
Topics: Acute Disease; Adult; Azathioprine; Blood Donors; Carrier State; Crohn Disease; DNA, Viral; False Ne | 2010 |
Hepatitis B virus-related polyarteritis nodosa presenting with multiple lung nodules and cavitary lesions.
Topics: Antiviral Agents; Biopsy, Needle; Diagnosis, Differential; DNA, Viral; Dose-Response Relationship, D | 2010 |
Steroid treatment in patients with membranous nephropathy and hepatitis B virus surface antigenemia: a report of two cases.
Topics: Aged; Female; Glomerulonephritis, Membranous; Hepatitis B Surface Antigens; Hepatitis B, Chronic; Hu | 2011 |
Polymyositis associated with hepatitis B: management with entacavir and prednisolone.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Guanine; Hepatitis B, Chronic; Humans; Middle A | 2011 |
Hepatitis B reactivation in a renal transplant patient due to a surface antigen mutant strain: a case report.
Topics: Antibodies, Monoclonal, Murine-Derived; Base Sequence; Biomarkers; Cyclosporine; DNA Mutational Anal | 2012 |
[Ulcerative colitis developed after acute exacerbation of chronic hepatitis B].
Topics: Acute Disease; Adult; Anti-Inflammatory Agents; Colectomy; Colitis, Ulcerative; Hepatitis B, Chronic | 2002 |
Repeated jaundice due to YMDD mutant in a patient with prolonged lamivudine therapy for chronic hepatitis B under prednisolone treatment for Still's disease.
Topics: Amino Acid Sequence; DNA, Viral; Drug Resistance, Viral; Female; Glucocorticoids; Hepatitis B, Chron | 2002 |
[Expression of extrahepatic symptoms in patients with chronic hepatitis B with low activity].
Topics: Adult; Antiviral Agents; Female; Hepatitis B, Chronic; Humans; Lamivudine; Prednisolone | 2002 |
[Evaluation in long-term observation of corticosteroid withdrawal therapy for chronic hepatitis type B].
Topics: Adult; Female; Hepatitis B, Chronic; Humans; Male; Prednisolone; Substance Withdrawal Syndrome | 1995 |
[A case of focal segmental glomerulosclerosis(FSGS) complicated with chronic hepatitis B and treated with steroid and LDL apheresis].
Topics: Anti-Inflammatory Agents; Blood Component Removal; Glomerulosclerosis, Focal Segmental; Hepatitis B, | 2002 |
[Severe exacerbation of chronic hepatitis B during therapy with corticosteroids and lamivudine therapy and successful short-term combination therapy with interferon-beta and interferon-gamma].
Topics: Anti-Inflammatory Agents; Antiviral Agents; Connective Tissue Diseases; Drug Therapy, Combination; F | 2003 |
A case of relapsing Guillain-Barré syndrome associated with exacerbation of chronic hepatitis B virus hepatitis.
Topics: Aged; Antigen-Antibody Complex; DNA, Viral; Guillain-Barre Syndrome; Hepatitis B Antibodies; Hepatit | 2003 |
Corticosteroids and lamivudine combined to treat acute severe flare-up in a chronic hepatitis B and C patient.
Topics: Acute Disease; Aged; Antiviral Agents; Betamethasone; Drug Therapy, Combination; Glucocorticoids; He | 2004 |
Response to interferon treatment with or without steroids in 20 children with chronic hepatitis B.
Topics: Adolescent; Child; Child, Preschool; DNA, Viral; Female; Hepatitis B, Chronic; Humans; Interferons; | 1989 |
The impact of HBV-DNA fluctuations on virus-specific CD8+ T cells in HBeAg+ chronic hepatitis B patients treated with a steroid and lamivudine.
Topics: Adult; Amino Acid Sequence; CD8-Positive T-Lymphocytes; DNA, Viral; Drug Therapy, Combination; Epito | 2006 |
Successful treatment with corticosteroid and lamivudine for autoimmune hepatitis in a patient with asymptomatic HBV infection.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Glucocorticoids; Hepatitis B, Chronic; Hepatiti | 2007 |
Outcomes of chronic hepatitis B infection in Oriental patients with rheumatic diseases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Asian People; Co | 2007 |
Acute hepatitis in an asthmatic patient.
Topics: Acute Disease; Adult; Asthma; Carrier State; Diagnosis, Differential; Glucocorticoids; Hepatitis B, | 1998 |
Treatment of chronic hepatitis B in children with prednisolone withdrawal followed by recombinant interferon alpha.
Topics: Adolescent; Alanine Transaminase; Child; Child, Preschool; DNA, Viral; Female; Hepatitis B, Chronic; | 1998 |
Case report: dramatic response to lamivudine therapy following corticosteroid priming in chronic hepatitis B.
Topics: Administration, Oral; Adult; Alanine Transaminase; Antiviral Agents; DNA, Viral; Drug Administration | 1999 |
Time course of histological changes in patients with a sustained biochemical and virological response to corticosteroid withdrawal therapy for chronic hepatitis B.
Topics: Adult; Alanine Transaminase; Analysis of Variance; Anti-Inflammatory Agents; Biopsy; Confidence Inte | 1999 |
Recurrence of hepatitis B after single lung transplantation.
Topics: Adult; Azathioprine; Female; Hepatitis B Antibodies; Hepatitis B, Chronic; Humans; Immunosuppression | 1999 |
Prednisolone priming enhances Th1 response and efficacy of subsequent lamivudine therapy in patients with chronic hepatitis B.
Topics: Adolescent; Adult; Alanine Transaminase; DNA, Viral; Drug Therapy, Combination; Female; Hepatitis B | 2000 |
Virological response to interferon therapy of chronic hepatitis B as measured by a highly sensitive assay.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Biological Assay; DNA, Viral; Female; Hepatitis B vir | 2001 |